Recurrent polypoidal lesions after achieving inactive polypoidal choroidal vasculopathy following 1-year fixed-dosing aflibercept treatments
Nearly half of inactive PCV eyes following 1-year fixed-dosing aflibercept treatments had recurrent polypoidal lesions. Eyes with high-risk features for recurrence, some of which can be detected with OCT without the need for ICGA, may warrant close monitoring.
Authors
- Nawat Watanachai (ORCID: https://orcid.org/0000-0003-3097-8694)
- Voraporn Chaikitmongkol (ORCID: https://orcid.org/0000-0003-0426-7602)
- Chanusnun Narongchai
- Titipol Srisomboon
- Apisara Sangkaew
- Direk Patikulsila (ORCID: https://orcid.org/0000-0002-0124-722X)
- Paradee Kunavisarut (ORCID: https://orcid.org/0000-0003-4997-6285)
- Phit Upaphong (ORCID: https://orcid.org/0000-0001-8590-8568)
- Janejit Choovuthayakorn (ORCID: https://orcid.org/0000-0001-5972-0270)
- Neil M. Bressler
- Wantip Tadadoltip
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Maharaj Nakorn Chiang Mai Hospital (TH)
- Nakornping Hospital (TH)
- Chiang Mai University (TH)
Publication Details
- Journal
- Asia-Pacific Journal of Ophthalmology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.apjo.2025.100176
- Citations
- 2
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.41
Funders
- Johns Hopkins University
- School of Medicine, Johns Hopkins University
- Faculty of Medicine, Chiang Mai University